Development of novel platforms for cancer immunotherapy
The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Tekes.
Twitter and News
Tutkija Erkko Ylösmäelle Vuoden Nuori Virologi -tunnustuspalkinto
Virustautien Tutkimussäätiö on myöntänyt Vuoden Nuori Virologi -palkinnon tutkijatohtori Erkko Ylösmäelle Helsingin yliopistosta. Ylösmäen...
Come and listen to the inaugural lectures of the new professors on 29 May 2019
A welcome reception after the lectures will feature a talk by Professor Vincenzo Cerullo, who specialises in the development of innovative...
Members of the ImmunoVIroTherapy Lab
The group consists of many experts and researchers with outstanding knowledge in the field of immunovirotherapy.